key: cord-0806326-wjnrp0ba
authors: Perlman, Jeffrey M.; Salvatore, Christine
title: COVID-19 Infection in Newborns
date: 2021-11-09
journal: Clin Perinatol
DOI: 10.1016/j.clp.2021.11.005
sha: 6c3e285d7872cfc31aad55d19d07cea1244b28ff
doc_id: 806326
cord_uid: wjnrp0ba

Maternal SARS-CoV-2 infection can present with or without symptoms at the time of birth. Symptomatic mothers are likely be associated with preterm births. However population studies, demonstrate a consistent association of SARS-CoV-2 infection and a reduction in preterm birth rate. Newborns with positive SARS-CoV-2 test results appeared to have minimal burden of illness that is directly associated with a viral infection. The reported incidence of positive neonatal SARS-CoV-2 PCR test ranges from 0.56 to 6.9%. Neonatal mortality directly related to SARSCoV-2 is extremely rare. Maternal vaccination in pregnant women leads to maternal antibody production and this can occur as early as 5 days after the first vaccination dose

of AF for SARS-CoV-2 was observed in a few cases. These findings indicate a strong likelihood that intrapartum vertical transmission of SARS-CoV-2 from mother to baby while rare is possible.

Single Case Reports Highlighting the Transplacental Vertical Passage of SARS-CoV-2 from Maternal to the Fetal Compartment (Table 2) We describe a series of cases (n=14) that highlight the potential small risk for the transplacental passage of the virus. (Table 2 ) There were four confirmed cases of transplacental passage of SARS-CoV-2, [26] [27] [28] [29] seven cases of probable infection, [30] [31] [32] [33] [34] [35] one possible case 36 and two cases of infection proximal to delivery. 37, 38 Summary These few cases of early-onset neonatal SARS-CoV-2 infection indicate that intrapartum vertical transmission of SARS-CoV-2 from mother to baby while rare occurs.

Infected infants with SARS-CoV-2 may be symptomatic or asymptomatic. Signs include early fever as well as respiratory and neurological symptoms. Improving access to molecular testing of AF, cord blood, urine, stool and breast milk, as well as cord blood antibody testing should be a priority to enable investigators to further describe the epidemiology of congenital and neonatal disease in the setting of maternal SARS-CoV-2 infection. J o u r n a l P r e -p r o o f Summary The above studies indicate that a symptomatic SARS-CoV-2 infected mother increases the risk for preterm and medically induced preterm birth. 39 An asymptomatic COVID-19 positive mother was not associated with an increased risk of neonatal morbidity. Two studies in this section highlight an important association of societal and health disparity and positive SARS-CoV-2 infection. Thus, mothers with a high social vulnerability index (≥ 90th percentile) were more likely to have neonates with positive SARS-CoV-2 test results. 40 In a second study a high proportion of newborns from Black, Asian, or minority ethnic groups were more likely to have newborns with positive SARS-CoV-2 infection. 41 Newborns with positive SARS-CoV-2 test results appear to have minimal burden of illness that is directly associated with a viral infection but rather through the impact of preterm delivery, undertaken because of the mother's worsening illness. 40 Preterm delivery affected a higher proportion of women than expected based on historical and contemporaneous national data. 43 The proportions of pregnancies affected by stillbirth, SGA infant or early neonatal death were comparable to those in historical and contemporaneous UK and USA data. The reported incidence of positive neonatal SARS-CoV-2 PCR test ranges from 0.56 to 2%. [40] [41] [42] [43] Finally, neonatal mortality as a result of SARS-CoV-2 is extremely rare.

The question of whether SARS-CoV-2 infection is associated with increased or decreased likelihood of premature births is important to delineate. From the preceding section, the evidence suggests that premature birth is more likely to occur in the setting of symptomatic J o u r n a l P r e -p r o o f mothers. Conversely, a reduction in premature birth rates has been suggested from population studies that may reflect a change in social behavior that occurred during the pandemic. Philip, et al 45 evaluated regional trends of very low birth weight (VLBW) (<1500g) and ELBW infants (<1000g) in one designated health area of Ireland over two decades (January to April 2001-2019) versus a similar time period in 2020. The regional historical VLBW rate per 1000 live births was 8.18 (95% CI 7.21 to 9.29) which was reduced to 2.17 per 1000 live births during the first 4 months of 2020, reflecting a rate ratio of 3.77 (95% CI 1.21 to 11.75)(p=0.02), representing a 73% reduction of VLBW. There were no ELBW infants admitted to the regional NICU during the four months in 2020. When the data was extended through June 30 th these observations persisted. during the study period. The PTB rate (<37 weeks) during the 2020 stay-at home order was lower than rates in previous years (10.2% vs 11.3%; p=0.003). Specifically, late preterm (35 to 36 6/7weeks' gestation) birth rates were also lower (5.8% vs 6.5%; p=0.03). There was no difference in GA <32 weeks (p=0.27). There was a higher rate of assisted ventilation during the pandemic versus the comparison period (4.5% vs 3.2%) (p<0.001) respectively. This extended to premature infants <37 weeks, i.e. 17.9 vs 12.3% (p<0.001) respectively. After accounting for maternal age, education, race/ethnicity, diabetes, and hypertension, the ratio for preterm birth . This nationwide study did not find any associations between being born during a period in 2020 and the risk for any of the preterm birth categories or stillbirth.

We reviewed data from our institution (New York Presbyterian Hospital) where PTB rates were compared for different GA categories for years 2017 to 2019 versus 2020. There was no difference in the number of births for the ELBW and VLBW infants but a significant reduction for the near term (34 to 36 6/7 week) newborn. (See Table 3 ) Summary There was a consistent association of SARS-CoV-2 infection and a reduction in PTB rates in five of the six studies reviewed. In two studies, 45, 46 there was a striking reduction in VLBW infants <28 weeks and/or <1500g ranging from 73 to 90%. A third study demonstrated a smaller reduction (11%) in the number of VLBW infants < 32 weeks. 44 One study demonstrated a 14% reduction noted in the late preterm infant, an effect that was similar to our own observations. 47 Why the reduction in PTB delivery rates? The COVID-19 pandemic lockdown drastically changed lives in many ways including a change in the working environment (work from home where possible), reducing physical interactions with a focus on hygiene (frequent hand washing, social distancing and wearing a mask). These changes may have influenced the overall inflammatory state of pregnant women.

It remains unclear whether the maternal immune response to infection protects the fetus.

Moreover, the impact of maternal vaccination on maternal and neonatal antibody production remains unclear. Flannery, et al 49 

Several studies have evaluated the placentas of mothers who were SARS-CoV-2 positive. The pathological findings appear to reflect whether the mother was asymptomatic or symptomatic. Breast milk was also positive on DOL 2 but not DOL 7. The neonate was discharge on DOL 4.

Kohorn, et al. 28 34-week GA 2414g male was born to a mother with a history of cough for Two cases. This first represents a mother who presented at 37 6/7 weeks GA who presented with a fever and a cough and had a positive NP swab for COVID. Delivery was vaginal. The BW was 2660 g. Apgar scores were 9 and 10 at 1 and 5 minutes, respectively. No skin-to-skin contact was permitted, however rooming-in and breastfeeding with a mask was allowed. The newborn had a positive result for COVID-19 from NP swabs obtained immediately after birth, and at DOL 1 and 7. The neonate remained asymptomatic and was discharged from the hospital at 10 days of life after being hospitalized for observation.

The second case represents a mother who presented at 35 1/7 weeks of gestation with a fever, cough, and a positive COVID-19 NP swab test.

Delivery was via CS. secondary to a nonreasoning fetal status. The The neonatal NP RT-PCR swab on DOL 1, was positive for SARS-CoV-2.

Maternal IgM and IgG were positive on postpartum day 4 (day 9 after symptom onset); neonatal immunoglobulins were negative. 9 Parsa, et al. 34 41-year-old mother who presented with signs and symptoms of acute respiratory illness including shortness of breath and cough. RT-PCR on the mother was positive and she was diagnosed with COVID-19

pneumonia. Delivery was via emergency CS. A term 3500g female infant was delivered with Apgar scores of 9 and 10 at 1 and 5-min respectively.

The RT-PCR results of the AF and neonate (< 24 hours after birth) were positive for COVID-19. She was admitted to the NICU and received routine care. She developed a fever on DOL 10; all tests were negative.

NP swabs were negative on DOL 11 and 14. She was discharged on DOL 28 in good condition.

Rogel, et al. 35 Term 3450 male infant born to a 19 year old asymptomatic mother via CS secondary to fetal bradycardia The mother roomed in with another mother-baby pair, both positive for SARS-CoV-2. On DOL 2, the neonate developed tachypnea with distress and a chest radiograph suggested pneumonia. On DOL 3, both the mother and newborn RT-PCR was positive for SARS-CoV-2; the mother remained asymptomatic. The neonate required mechanical ventilation and was transferred to a and fever with positive testing for SARS-CoV-2. After 3 days she underwent a CS and delivered a 30 5/7-week 2350g female infant with Apgar scores of 9 and 9 at one and five minute respectively. The infant exhibited initial fever and was treated with antibiotics. She recovered and was without issues by DOL 8. Cultures from the amniotic fluid and from the NP at DOL 1 and 7 were positive for SARS-CoV-2. 12 Dong, et al. 22 29-year-old gravida 1 para 0 mother who presented one month prior to delivery at 34 2/7week gestation suspected of being exposed to SARS- The breastfed infant was not tested. No replication-competent virus was detectable in any sample, including the sample that tested positive for viral RNA.

Following Holder pasteurization, viral RNA was not detected by RT-PCR in the 2 samples that had been spiked with replication-competent SARS-CoV-2, nor was culturable virus detected. However, virus was detected by culture in nonpasteurized aliquots of the same 2 milk-virus mixtures. These findings are reassuring given the known benefits of breastfeeding and human milk provided through milk banks.

J o u r n a l P r e -p r o o f

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents. A Systematic Review

Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults. A Systematic Review and Metaanalysis

Children with Covid-19 in Pediatric Emergency Departments in Italy

SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review

Multisystem Inflammatory Syndrome in Children in New York State

Management of Infants Born to Mothers with COVID-19

Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection

Evaluation and Management Considerations for Neonates At Risk for COVID-19

Neonatal management and outcomes during the COVID-19 pandemic

COVID-19 and Neonatal Respiratory Care: Current Evidence and Practical Approach

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain

Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center

Sequential Analysis of Viral Load in a Neonate and Her Mother Infected With Severe Acute Respiratory Syndrome Coronavirus 2

Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding

Perinatal characteristics and delivery room management of infants born through MSAF

SARS-COV-2 Maternal-Child Transmission: Can It Occur Before Delivery and How Do We Prove It?

The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study

Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates

Can SARS-CoV-2 Infection Be Acquired In Utero? More Definitive Evidence Is Needed

Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn

Antibodies in Infants Born to Mothers With COVID-19 Pneumonia

Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic

Retrospective observational RT-PCR analyses on 688 babies born to 843 SARS-CoV-2 positive mothers, placental analyses and diagnostic analyses limitations suggest vertical transmission is possible. Facts Views Vis Obgyn

Transplacental transmission of SARS-CoV-2 infection

Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection

Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms

Intrauterine Transmission of SARS-COV-2 Infection in a Preterm Infant

Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth

A Possible Case of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Newborn With Positive Placental In Situ Hybridization of SARS-CoV-2 RNA

Severe COVID-19 during Pregnancy and Possible Vertical Transmission

Possible Vertical Transmission of COVID-19 to the Newborn; a Case Report

Perinatal COVID-19: a case report, literature review, and proposal of a national system for case record

Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection

Case Series of COVID-19 Asymptomatic Newborns With Possible Intrapartum Transmission of SARS-CoV-2. Front Pediatr

Possible Early Vertical Transmission of COVID-19 from an Infected Pregnant Female to Her Neonate: A Case Report

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without

Infection: The INTERCOVID Multinational Cohort Study

Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts

Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance

Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes

Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries

Perinatal Outcomes During the COVID-19 Pandemic in Ontario, Canada

Unprecedented reduction in births of very low birthweight (VLBW) and extremely low birthweight (ELBW) infants during the COVID-19 lockdown in Ireland: a 'natural experiment' allowing analysis of data from the prior two decades

Danish premature birth rates during the COVID-19 lockdown

Association of Preterm Birth Rate With COVID-19 Statewide Stay-at-Home Orders in Tennessee

Preterm Birth and Stillbirth During the COVID-19 Pandemic in Sweden: A Nationwide Cohort Study

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios

SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage into Cord Blood

Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women

COVID-19 as an independent risk factor for subclinical placental dysfunction

Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2

SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers

SARS-CoV-2 infection of the placenta

SARS-CoV-2 Infects Syncytiotrophoblast and Activates Inflammatory Responses in the Placenta. bioRxiv